Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychological Characteristics of Fathers of People With Bulimia Nervosa: A Systematic Review.

The International journal of eating disorders·2024
Same author

A spatialized assessment of ecosystem service relationships in a multifunctional agroforestry landscape of Senegal.

The Science of the total environment·2022
Same author

Pollutant source or sink? Adsorption and mobilization of PFOS and PFOA from sediments in a large shallow lake with extended reed belt.

Journal of environmental management·2022
Same author

Body dysmorphic disorder, muscle dysmorphia, weight and shape dissatisfaction and the use of appearance-enhancing drugs in the military: a systematic review.

BMJ military health·2022
Same author

Interruption of outpatient follow-up in physical and rehabilitation medicine: Observational cross-sectional study of deleterious consequences of the first COVID-19 lockdown in France.

Annals of physical and rehabilitation medicine·2021
Same author

Host traits, lifestyle and environment are associated with human skin bacteria.

The British journal of dermatology·2021

Related Experiment Video

Updated: May 31, 2026

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

Gene-PUFA interactions and obesity risk.

C Jourdan1, S Kloiber, A Nieters

  • 1Institute of Epidemiology, Helmholtz Zentrum München, German Research Centre for Environmental Health, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany.

The British Journal of Nutrition
|July 9, 2011
PubMed
Summary

Polyunsaturated fatty acids (PUFA) may modify obesity risk associated with specific gene variants. Higher PUFA intake, particularly linoleic and arachidonic acid, correlated with reduced obesity risk in carriers of certain gene variants, notably IL-6.

More Related Videos

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
09:38

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans

Published on: November 29, 2013

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
13:09

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography

Published on: April 4, 2012

Related Experiment Videos

Last Updated: May 31, 2026

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
09:38

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans

Published on: November 29, 2013

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
13:09

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography

Published on: April 4, 2012

Area of Science:

  • Nutritional genomics
  • Obesity research
  • Human genetics

Background:

  • Limited human data exists on polyunsaturated fatty acids (PUFA) modulating the link between single nucleotide polymorphisms (SNPs) and obesity risk.
  • Investigating gene-PUFA interactions is crucial for understanding obesity etiology.

Purpose of the Study:

  • To examine the interaction effects between SNPs in obesity-related genes and erythrocyte membrane PUFA levels on obesity risk in adults.
  • To identify specific gene variants and PUFA that influence obesity susceptibility.

Main Methods:

  • Cross-sectional analysis of 568 adults from the Bavarian Food Consumption Survey.
  • Gas chromatography (GC) for erythrocyte membrane fatty acid composition.
  • Genotyping for 21 candidate genes and measurement of plasma IL-6 concentrations.
  • Logistic regression modeling for additive genetic effects.

Main Results:

  • Significant interactions between PUFA and gene variants (IL-2, IL-6, IL-18, TNFRSF1B, TNFRSF21, LEPR, ADPN) were observed for obesity risk.
  • Strongest effects noted for rs2069779 (IL-2) with all PUFA and rs1800795 (IL-6) with linoleic/arachidonic acid.
  • Obesity risk decreased with higher fatty acid content in minor allele carriers, particularly for IL-6 variants.
  • The PUFA-IL-6 genetic interaction was reflected in plasma IL-6 levels.

Conclusions:

  • Polyunsaturated fatty acids may exert regulatory effects on obesity risk through interactions with specific gene variants.
  • High PUFA intake, especially linoleic and arachidonic acid, may offer a protective effect against obesity for individuals with certain genetic profiles.
  • Further prospective studies are needed to confirm these findings and their public health implications.